CORC

在结果中检索

CORC

浏览/检索结果: 共33条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
EFFICACY, PHARMACOKINETICS, SAFETY AND IMMUNOGENICITY OF THE BIOSIMILAR HS016 IN COMPARISON WITH ADALIMUMAB IN CHINESE PATIENTS WITH ANKYLOSING SPONDYLITIS: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PHASE 3 TRIAL 会议论文
ANNALS OF THE RHEUMATIC DISEASES, 2019-06-01
作者:  Su, Jinmei;  Li Mengtao;  Zeng, Xiaofeng
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
BIOSIMILAR BAT1406 VERSUS ADALIMUMAB THERAPY ON ACTIVE ANKYLOSING SPONDYLITIS: A RANDOMIZED, DOUBLE-BLINDED, MULTICENTER, CONTROLLED PHASE 3 TRIAL 会议论文
Annual European Congress of Rheumatology (EULAR), JUN 12-15, 2019
作者:  Tu, Liudan;  Wei, Qiujing;  Xie, Ya;  Shi, Guixiu;  Liu, Huaxiang
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/31
A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 会议论文
作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Progression-free survival results in postmenopausal Asian women: Subgroup analysis from a phase 3 randomized trial of fulvestrant 500 mg vs anastrozole for hormone receptor-positive advanced breast cancer (FALCON) 会议论文
作者:  Fazal, M.;  Shao, Z.;  Ellis, M. J.;  Robertson, J. F. R.;  Grinsted, L. M.
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05
CLASS-05 trial: A randomized controlled phase III trial of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy vesus systemic chemotherapy alone for patients with limited peritoneal carcinomatosis of gastric cancer 会议论文
作者:  Liu, H.;  Li, G.;  Yu, J.;  Su, X.;  Sun, Y.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Comparison of efficacy and safety of first-line palliative chemotherapy with TX and XELOX regimens in patients with metastatic gastric adenocarcinoma: A randomized phase II trial. 会议论文
作者:  Zhu, Xiaodong;  Li, Jin;  Zhao Xiaoying;  Guo, Weijian;  Liu, Xin
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
A Randomized Phase 3 Trial of Capecitabine With or Without Irinotecan Driven By UGT1A1 in Neoadjuvant Chemoradiation of Locally Advanced Rectal Cancer (CinClare): Results of Interim Analysis 会议论文
作者:  Zhu, J.;  Zhang, Z.;  Sun, X.;  Wang, X.;  Zhang, T.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
A randomized phase III trial of capecitabine with or without irinotecan driven by UGT1A1 in neoadjuvant chemoradiation of locally advanced rectal cancer (CinClare). 会议论文
作者:  Zhu, Ji;  Sun, Xinchen;  Zhang, Tao;  Liu, Anwen;  Zhu, Yuan
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
LATITUDE, a phase 3 double-blind, randomized trial of androgen deprivation therapy (ADT) with abiraterone acetate (AA) plus prednisone (P) or placebos (PBOs) in patients (pts) with newly diagnosed high-risk metastatic hormone-naive prostate cancer (mHNPC) 会议论文
作者:  Feyerabend, S.;  Tran, N.;  Fein, L.;  Matsubara, N.;  Rodriguez Antolin, A.
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
A randomized, double-blind, placebo-controlled, multi-centered phase 3 trial comparing fruquintinib versus placebo plus best supportive care in Chinese patients with metastatic colorectal cancer (FRESCO). 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Li, Jin;  Qin, Shukui;  Bai, Yuxian;  Deng, Yanhong;  Yang, Lei
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/04

©版权所有 ©2017 CSpace - Powered by CSpace